Pilot Study of Neoantigen Peptides for the Treatment of Neoplasms

Summary

This research is a pilot clinical trial using personalized neoantigen peptide vaccines with an adjuvant (Montanide ISA-51 VG), in patients with different types of cancer

Timeline

Start

2020-08-10

Primary completion

2022-06-24

Completion

2022-06-24

Drugs

Indications